Research News and Research

RSS

Republicans plan to chip away at health law; Senators call for insurance rate hearings

The New York Times: Republicans are hopeful they can pick up enough seats in November's midterm elections to chip away at the new health law. "This goal, though not fleshed out in a detailed legislative proposal, is much more than a campaign slogan. That conclusion emerged from interviews with a wide range of Republican lawmakers, who said they were determined to chip away at the law if they could not dismantle it." Republicans are expected to release specifics of the plan Thursday.

22 Sep 2010

NIH awards UCSF $15.4 million to set up new National Center for Systems Biology

Cell biologists at UCSF have received $15.4 million from the National Institutes of Health to set up one of two new National Centers for Systems Biology, to study how cells respond to their environment - an emerging field of research that could revolutionize medicine by creating "smart cells" to deliver medications and other therapeutics more effectively.

22 Sep 2010

Sebelius: Medicare Advantage premium costs to decline slightly in 2011

The Associated Press: "Seniors enrolled in popular private health insurance plans through Medicare will pay a little less on average next year, the Obama administration said Tuesday. The average monthly premium in so-called Medicare Advantage plans will dip to $35.69 in 2011, a 45-cent reduction from $36.14 this year, Medicare officials said."

22 Sep 2010

Sun Pharma completes acquisition of controlling stake in Taro

Sun Pharmaceutical Industries Ltd. today announced that it has completed the acquisition of a controlling stake in Taro Pharmaceutical Industries Ltd. pursuant to the Option Agreement entered into in 2007 with Taro's controlling shareholders led by Taro's Chairman, Dr. Barrie Levitt.

22 Sep 2010

Obesity hurts wallets and health, especially in women

The Associated Press: Obese women incur higher costs, both to their health and wallets, than men, according to a new study by researchers at George Washington University. "George Washington University researchers added in things like employee sick days, lost productivity, even the need for extra gasoline — and found the annual cost of being obese is $4,879 for a woman and $2,646 for a man.

22 Sep 2010

HIV infection mystery revealed

In a new discovery, Melbourne researchers have found a mechanism by which the HIV virus can affect people. According to co-head of the Burnet Institute's Centre for Virology, Sharon Lewin, scientists have found out how HIV entered a group of cells in which the virus tends to persist in spite of antiviral treatment that reduces the virus to undetectable levels.

22 Sep 2010

Sinobiopharma fiscal 2010 total revenue increases 101% YoY to $7.7 million

Sinobiopharma, Inc., a fully integrated and highly innovative specialty pharmaceutical company engaged in the research, development, manufacture, and marketing of biopharmaceutical products in China, announced financial results for the fiscal year ended May 31, 2010.

22 Sep 2010

Few insurers provide coverage for weight loss treatment

Reporting for Kaiser Health News, in collaboration with The Washington Post, Sandra G. Boodman writes: "After her weight hit the obese range, her cholesterol level nudged the danger zone and her doctor urged her to lose weight, Melissa Moss, veteran of a decade of failed diets, decided she needed intensive help.

22 Sep 2010

Health overhaul details trigger uncertainty, debate

The Orlando Sentinel: "It's one of the most overlooked pieces of health-care overhaul, but a plan to help companies pay health-care costs for early retirees has proved popular in Florida, where 69 companies and government agencies have applied for federal help.

22 Sep 2010

Brown grants exclusive intellectual property license to Tivorsan Pharmaceuticals

Development of a potential treatment for the most common form of muscular dystrophy is moving into a new phase at Brown University. Brown has granted an exclusive license for the intellectual property to Tivorsan Pharmaceuticals, a startup firm that will strive to see it through human trials.

22 Sep 2010

AIG Co. caught selling 'bogus' health plans

Minneapolis Star Tribune: A subsidiary of American International Group — known as AIG — has been fined $100,000 by Minnesota regulators for selling "bogus" health policies and is now ordered to repay its customers.

22 Sep 2010

High dose aspirin effective for treatment of severe headache and migraine

An inexpensive, hundred-year-old therapy for pain - aspirin - is effective in high doses for the treatment of severe headache and migraine caused by drug withdrawal, according to a new study by researchers with the UCSF Headache Center. Study participants were administered aspirin through an IV and 25 percent of the time they reported a significant reduction in pain - three points on the 10-point pain scale.

22 Sep 2010

A slow, steady move to health IT

Reuters: More physicians are using health IT. "U.S. doctors increasingly are ditching pen and paper and sending prescriptions to pharmacies electronically, lured by up to $27 billion in government funds aimed at speeding the switch to electronic medical records. There are now 200,000 doctors who use e-prescribing, or roughly one in three office-based doctors." E-prescribing is only one piece of the health IT puzzle doctors must solve to get their share of the funds (Steenhuysen, 9/21).

22 Sep 2010

Echo commences development of new transdermal biosensor for continuous lactate monitoring

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced that it is beginning a development program designed to create a new transdermal biosensor for continuous lactate monitoring to be used in critical care and sports medicine.

21 Sep 2010

Biodegradable polymers represent future of stent design

Three-year data demonstrated that satisfactory clinical and safety outcomes of sirolimus eluting stents with a biodegradable polymer were sustained in a real world setting. The results were presented at the 22nd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation.

21 Sep 2010

MD Analytics releases early results from annual Pharmacists Prescribing report

Health industry marketing research leader MD Analytics® released early results today from its annual Insight Syndication Report: Pharmacists Prescribing.

21 Sep 2010

Incidence of hockey-related injuries among children doubles

The incidence of hockey-related injuries among children aged 9 to 14 leading to emergency department visits more than doubled between 1990 and 2006, according to a new nationwide study.

21 Sep 2010

Aethlon Medical reestablishes efforts to advance Aethlon Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, disclosed today that it has reestablished efforts to advance the Aethlon Hemopurifier within U.S. Government programs that support the development and purchase of treatment countermeasures against bioterror threats.

21 Sep 2010

Lehigh Valley Health Network automates IRB processes with Click Commerce eResearch Portal software

Click Commerce, the pioneer in customer-configurable solutions for the business of research, announced today that Lehigh Valley Health Network (LVHN) will use the company's eResearch Portal software to automate its Institutional Review Board (IRB) processes, which monitor the safe and ethical conduct of research involving human subjects.

21 Sep 2010

Phenex Pharmaceuticals announces closure of Series C financing round

Phenex Pharmaceuticals AG, a drug discovery and development company headquartered in Ludwigshafen, Germany, today announced the closure of its Series C financing round with a volume of 6 M € (7,8 M USD) bringing the total amount of funds raised to 17,2 M € (22,4 M USD).

21 Sep 2010